Sanarus introduces breast biopsy
Pleasanton, CA-based Sanarus Medical may soon bring to market an ultrasound-guided biopsy tool called Centrica. The product, described as a rotational core biopsy system, uses a new approach to breast tissue sampling that the company considers more
Pleasanton, CA-based Sanarus Medical may soon bring to market an ultrasound-guided biopsy tool called Centrica. The product, described as a rotational core biopsy system, uses a new approach to breast tissue sampling that the company considers more cost-effective and less invasive than open, surgical biopsy options. The procedure creates a 3 to 4-mm incision in the breast and requires no general anesthesia or stitches. Under ultrasound visualization, a small needle is placed directly into the tissue. Once placement is confirmed via ultrasound, the immobilized lesion is “stick frozen” for a few seconds, which secures the targeted tissue and enables a large tissue sample to be removed for evaluation. Centrica, which has been cleared by the FDA, is the first in a series of ultrasound-guided technologies being developed by Sanarus.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
